These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34697370)

  • 1. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer.
    Ruff SE; Vasilyev N; Nudler E; Logan SK; Garabedian MJ
    Commun Biol; 2021 Oct; 4(1):1221. PubMed ID: 34697370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.
    Ha S; Iqbal NJ; Mita P; Ruoff R; Gerald WL; Lepor H; Taneja SS; Lee P; Melamed J; Garabedian MJ; Logan SK
    Oncogene; 2013 Aug; 32(34):3992-4000. PubMed ID: 22986532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
    Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
    J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells.
    van der Poel HG; Zevenhoven J; Bergman AM
    Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
    Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
    Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of androgen receptor-dependent transcription by the serine/threonine kinase Pim-1.
    Thompson J; Peltola KJ; Koskinen PJ; Jänne OA; Palvimo JJ
    Lab Invest; 2003 Sep; 83(9):1301-9. PubMed ID: 13679438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
    Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
    Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen Receptor and
    Ntzifa A; Strati A; Koliou GA; Zagouri F; Pectasides D; Pentheroudakis G; Christodoulou C; Gogas H; Magkou C; Petraki C; Kosmidis P; Aravantinos G; Kotoula V; Fountzilas G; Lianidou E
    Cancer Genomics Proteomics; 2021; 18(2):147-156. PubMed ID: 33608311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
    Zippo A; De Robertis A; Serafini R; Oliviero S
    Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
    Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
    Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
    Holder SL; Abdulkadir SA
    Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.
    Magistroni V; Mologni L; Sanselicio S; Reid JF; Redaelli S; Piazza R; Viltadi M; Bovo G; Strada G; Grasso M; Gariboldi M; Gambacorti-Passerini C
    PLoS One; 2011; 6(11):e28162. PubMed ID: 22140532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
    Weber H; Ruoff R; Garabedian MJ
    PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition.
    van der Meer R; Song HY; Park SH; Abdulkadir SA; Roh M
    Clin Cancer Res; 2014 Jun; 20(12):3211-21. PubMed ID: 24771642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.
    Li Z; Lin F; Zhuo C; Deng G; Chen Z; Yin S; Gao Z; Piccioni M; Tsun A; Cai S; Zheng SG; Zhang Y; Li B
    J Biol Chem; 2014 Sep; 289(39):26872-26881. PubMed ID: 25096571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.
    Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A
    PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
    Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
    Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.
    Jensen CC; Clements AN; Liou H; Ball LE; Bethard JR; Langlais PR; Toth RK; Chauhan SS; Casillas AL; Daulat SR; Kraft AS; Cress AE; Miranti CK; Mouneimne G; Rogers GC; Warfel NA
    J Cell Biol; 2023 Jun; 222(6):. PubMed ID: 37042842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
    PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.